Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-29T08:39:25.612Z Has data issue: false hasContentIssue false
  • English
  • Français

Ataxia-Telangiectasia: Atypical Presentation and Toxicity of Cancer Treatment

Published online by Cambridge University Press:  02 December 2014

Rochelle A. Yanofsky ,
Sashi S. Seshia ,
Angelika J. Dawson ,
Kent Stobart ,
Cheryl R. Greenberg ,
Frances A. Booth ,
Chitra Prasad ,
Marc R. Del Bigio ,
Jens J. Wrogemann  and
Francesca Fike
...Show all authors
Rochelle A. Yanofsky*
Affiliation:
Section of Pediatric Hematology/Oncology, University of Manitoba & Health Sciences Centre, Winnipeg, MB Department of Pediatrics & Child Health, University of Manitoba & Health Sciences Centre, Winnipeg, MB
Sashi S. Seshia
Affiliation:
Section of Pediatric Neurology, Department of Pediatrics, University of Saskatchewan, Saskatoon, SK
Angelika J. Dawson
Affiliation:
Department of Pediatrics & Child Health, University of Manitoba & Health Sciences Centre, Winnipeg, MB Departments of Biochemistry & Medical Genetics, University of Manitoba & Health Sciences Centre, Winnipeg, MB Division of Laboratory Medicine & Pathology, Section of Genetics and Metabolism, University of Manitoba & Health Sciences Centre, Winnipeg, MB University of Manitoba & Health Sciences Centre, Winnipeg, MB
Kent Stobart
Affiliation:
Section of Pediatric Hematology/Oncology, University of Manitoba & Health Sciences Centre, Winnipeg, MB Department of Pediatrics, Northern Alberta Children's Cancer Program, University of Alberta, Edmonton, AB
Cheryl R. Greenberg
Affiliation:
Department of Pediatrics & Child Health, University of Manitoba & Health Sciences Centre, Winnipeg, MB Departments of Biochemistry & Medical Genetics, University of Manitoba & Health Sciences Centre, Winnipeg, MB
Frances A. Booth
Affiliation:
Department of Pediatrics & Child Health, University of Manitoba & Health Sciences Centre, Winnipeg, MB
Chitra Prasad
Affiliation:
Department of Pediatrics, University of Western Ontario, London, ON, Canada
Marc R. Del Bigio
Affiliation:
University of Manitoba & Health Sciences Centre, Winnipeg, MB Department of Pathology, UCLA/Geffen School of Medicine, Los Angeles, CA, USA
Jens J. Wrogemann
Affiliation:
University of Manitoba & Health Sciences Centre, Winnipeg, MB Diagnostic Imaging, Section of Pediatric Radiology, UCLA/Geffen School of Medicine, Los Angeles, CA, USA
Francesca Fike
Affiliation:
Departments of Pathology & Laboratory Medicine and Human Genetics, UCLA/Geffen School of Medicine, Los Angeles, CA, USA
Richard A. Gatti
Affiliation:
Departments of Pathology & Laboratory Medicine and Human Genetics, UCLA/Geffen School of Medicine, Los Angeles, CA, USA
*
Section of Pediatric Hematology/Oncology, CancerCare Manitoba, 675 McDermot Ave., Winnipeg, Manitoba, R3E 0V9, Canada
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

The onset of progressive cerebellar ataxia in early childhood is considered a key feature of ataxiatelangiectasia (A-T), accompanied by ocular apraxia, telangiectasias, immunodeficiency, cancer susceptibility and hypersensitivity to ionizing radiation.

Methods:

We describe the clinical features and course of three Mennonite children who were diagnosed with A-T following the completion of therapy for lymphoid malignancies.

Results:

Prior to cancer therapy, all had non-progressive atypical neurological abnormalities, with onset by age 30 months, including dysarthria, dyskinesia, hypotonia and/or dystonia, without telangiectasias. Cerebellar ataxia was noted in only one of the children and was mild until his death at age eight years. None had severe infections. All three children were “cured” of their lymphoid malignancies, but experienced severe adverse effects from the treatments administered. The two children who received cranial irradiation developed supratentorial primitive neuroectodermal tumors of the brain, an association not previously described, with fatal outcomes.

Conclusions:

The range of neurological presentations of A-T is broad. Ataxia and telangiectasias may be minimal or absent and the course seemingly non-progressive. The diagnosis of A-T should be considered in all children with neuromotor dysfunction or peripheral neuropathy, particularly those who develop lymphoid malignancies. The consequences of missing the diagnosis may be dire. Radiation therapy and radiomimetic drugs should be avoided in individuals with A-T.

Résumé:

RÉSUMÉ:Contexte :

L’apparition d’une ataxie cérébelleuse progressive dans la petite enfance est considérée comme une manifestation clé de l’ataxie-télangiectasie (A-T), accompagnée d’apraxie oculaire, de télangiectasies, d’un déficit immunitaire, de susceptibilité au cancer et d’hypersensibilité aux radiations ionisantes.

Méthodes :

Nous décrivons les manifestations cliniques et l’évolution chez trois enfants mennonites chez qui un diagnostic d’A-T a été posé après un traitement pour cancer lymphoïde.

Résultats :

Avant le traitement anticancéreux, tous présentaient des anomalies neurologiques atypiques non évolutives, dont l’âge de début se situait vers 30 mois, soit de la dysarthrie, des dyskinésies, de l’hypotonie et/ou de la dystonie sans télangiectasies. Une ataxie cérébelleuse a été notée chez un seul des enfants et elle est demeurée légère jusqu’à son décès à l’âge de huit ans. Aucun n’a présenté d’infection grave. Les trois enfants ont été « guéris » de leur cancer lymphoïde. Cependant tous ont présenté des effets secondaires du traitement. Les deux enfants qui ont reçu une irradiation crânienne ont présenté des tumeurs cérébrales neuroectodermiques primitives sus-tentorielles, une association jamais décrite auparavant, dont l’issue a été fatale.

Conclusions :

Le mode de présentations neurologiques de l’A-T est vaste. L’ataxie et les télangiectasies peuvent être minimes ou absentes et sans évolution apparente. Le diagnostic d’A-T devrait être envisagé chez tous les enfants qui présentent une dysfonction neuromotrice ou une neuropathie périphérique, surtout chez ceux qui présentent éventuellement un cancer lymphoïde. Si le diagnostic n’est pas posé, les conséquences peuvent être sérieuses. La radiothérapie et les médicaments radiomimétiques devraient être évités chez les individus atteints d’A-T.

Type
Original Article
Information
Canadian Journal of Neurological Sciences , Volume 36 , Issue 4 , July 2009 , pp. 462 - 467
Copyright
Copyright © The Canadian Journal of Neurological 2009

References

1. Chun, HH, Gatti, RA. Ataxia telangiectasia, an evolving phenotype. DNA Repair. 2004;3:1187–96.Google Scholar
2. Regueiro, JR, Porras, O, Lavin, M, Gatti, RA. Ataxia-Telangiectasia. A primary immunodeficiency revisited. Immunol Allergy Clin N Am. 2000;20:177–206.Google Scholar
3. Spacey, SD, Gatti, RA, Bebb, G. The molecular basis and clinical management of ataxia telangiectasia. Can J Neurol Sci. 2000;27:184–91.Google Scholar
4. Crawford, TO. Ataxia Telangiectasia. Sem Pediatr Neurol. 1998;5:287–94.CrossRefGoogle ScholarPubMed
5. Gatti, RA, Boder, E, Vinters, HV, Sparkes, RS, Norman, A, Lange, K. Ataxia-Telangiectasia: an interdisciplinary approach to pathogenesis. Medicine. 1991;70:99–117.Google Scholar
6. Boder, E. Ataxia-telangiectasia: an overview. In: Gatti, RA, Swift, A, editors. Ataxia-telangiectasia: genetics, neuropathology, and immunology of a degenerative disease of childhood. New York, NY: Alan R. Liss;1985. p. 1–63.Google Scholar
7. Gatti, RA, Good, RA. Occurrence of malignancy in immunodeficiency diseases. Cancer. 1971;28:89–98.Google Scholar
8. Boder, E, Sedgwick, RP. Ataxia-Telangiectasia. A familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia, and frequent pulmonary infection. Pediatrics. 1958;21:526–54.CrossRefGoogle ScholarPubMed
9. Morrell, D, Cromartie, E, Swift, M. Mortality and cancer incidence in 263 patients with ataxia telangiectasia. J Natl Cancer Inst. 1986;(77):89–92.Google Scholar
10. Taylor, AMR, Metcalfe, JA, Thick, J, Mak, Y-F. Leukemia and lymphoma in ataxia telangiectasia. Blood. 1996;87:423–38.Google Scholar
11. Gatti, RA. Ataxia-telangiectasia. In: Scriver, CR, Beaudet, AL, Sly, WS, Valle, D, editors. The metabolic & molecular bases of inherited disease. 8th ed. New York, NY: McGraw-Hill; 2001. p. 705–21.Google Scholar
12. Cabana, MD, Crawford, TO, Winkelstein, JA, Christensen, JR, Lederman, HMl. Consequences of the delayed diagnosis of ataxia-telangiectasia. Pediatrics. 1998;102:98–100.Google Scholar
13. Gilad, S, Chessa, L, Khosravi, R, Russell, P, Galanty, Y, Piane, M, et al. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am J Hum Genet. 1998;62:551–61.Google Scholar
14. Alterman, N, Fattal-Valevski, A, Moyal, L, Crawford, TO, Lederman, HM, Ziv, Y, et al. Ataxia-telangiectasia: mild neurological presentation despite null ATM mutation and severe cellular phenotype. Am J Med Genet A. 2007;143:1827–34.Google Scholar
15. Crawford, TO, Skolasky, RL, Fernandez, R, Rosquist, KJ, Lederman, HM. Survival probability in ataxia telangiectasia. Arch Dis Child. 2006;91:610–11.Google Scholar
16. Taylor, AMR, Byrd, PJ. Molecular pathology of ataxia telangiectasia. J Clin Pathol. 2005;58:1009–15.CrossRefGoogle ScholarPubMed
17. Trimis, GG, Athanassaki, CK, Kanariou, MM, Giannoulia-Karantana, AA. Unusual absence of neurologic symptoms in a six-year old girl with ataxia-telangiectasia. J Postgrad Med. 2004; 50:270–1.Google Scholar
18. Taylor, AMR, Groom, A, Byrd, PJ. Ataxia-telangiectasia-like disorder (ATLD)-its clinical presentation and molecular basis. DNA Repair. 2004;3:1219–25.Google Scholar
19. Sutton, IJ, Last, JIK, Ritchie, SJ, Harrington, HJ, Byrd, PJ, Taylor, AMR. Adult-onset ataxia telangiectasia due to ATM 5762ins137 mutation homozygosity. Ann Neurol. 2004;55:891–5.CrossRefGoogle ScholarPubMed
20. Dork, T, Bendix-Waltes, R, Wegner, R-D, Stumm, M. Slow progression of ataxia-telangiectasia with double missense and in frame splice mutations. Am J Med Genet. 2004;126A:272–7.CrossRefGoogle ScholarPubMed
21. Saviozzi, S, Saluto, A, Taylor, AMR, Last, JIL, Trebini, F, Paradiso, MC, et al. A late onset variant of ataxia-telangiectasia with a compound heterozygous genotype, A8030G/7481insA. J Med Genet. 2002;39:57–61.Google Scholar
22. Goyal, V, Behari, M. Dystonia as presenting manifestation of ataxia telangiectasia: a case report. Neurol India. 2002;50:187–9.Google Scholar
23. Crawford, TO, Mandir, AS, Lefton-Greif, MA, Goodman, SN, Goodman, SN, Sengul, H, et al. Quantitative neurologic assessment of ataxia-telangiectasia. Neurology. 2000;54:1505–09.CrossRefGoogle ScholarPubMed
24. Lavin, MF, Concannon, P, Gatti, RA. Eighth international workshop on ataxia-telangiectasia (ATW8). Cancer Res. 1999;59:3845–9.Google ScholarPubMed
25. Larnaout, A, Belal, S, Ben Hamida, C, Ben Hamida, L, Hentatif, F. Atypical ataxia telangiectasia with early childhood lower motor neuron degeneration: a clinicopathological observation in three siblings. J Neurol. 1998;245:231–5.Google Scholar
26. Klein, C, Wenning, GK, Quinn, NP, Marsden, CD. Ataxia without telangiectasia masquerading as benign hereditary chorea. Mov Disord. 1996;11:217–20.Google Scholar
27. McConville, CM, Stankovic, T, Byrd, PJ, McGuire, QYY, Lennox, GG, Taylor, MR. Mutations associated with variant phenotypes in ataxia-telangiectasia. Am J Hum Genet. 1996;59:320–30.Google Scholar
28. Bodensteiner, JB, Goldblum, RM, Goldman, AS. Progressive dystonia masking ataxia in ataxia-telangiectasia. Arch Neurol. 1980;37:464–5.Google Scholar
29. Verhagen, MM, van Alfen, N, Pillen, S, Weemaes, CM, Yntema, JL, Hiel, JAP, et al. Neuromuscular abnormalities in ataxia telangiectasia: a clinical, electrophysiological and muscle ultrasound study. Neuropediatrics. 2007;38:117–21.Google Scholar
30. Willems, PJ, Van Roy, BC, Kleijer, WJ, Van der Kraan, M, Martin, JJ. Atypical clinical presentation of ataxia telangiectasia. Am J Med Genet. 1993;45:777–82.Google Scholar
31. Wong, V, Yu, YL, Chan-Lui, WY, Woo, E, Yeung, CY. Ataxia telangiectasia in Chinese children. A clinical and electrophysiological study. Clin Neurol Neurosurg. 1987;89:137–144.Google Scholar
32. Barbieri, F, Santoro, L, Crisci, C, Massini, R, Russo, E, Campanella, G. Is the sensory neuropathy in ataxia telangiectasia distinguishable from that in Friedreich’s ataxia? Morphometric and ultrastructural study of the sural nerve in a case of Louis Bar syndrome. Acta Neuropathol. 1986;69:213–19.Google Scholar
33. Lewis, RF, Crawford, TO. Slow target-directed eye movements in ataxia-telangiectasia. Invest Opthalmol Vis Sci (IVOS). 2002;43:686–91.Google Scholar
34. Lewis, RF, Lederman, HM, Crawford, TO. Ocular motor abnormalities in ataxia telangiectasia. Ann Neurol. 1999;46: 287–95.Google Scholar
35. Chun, HH, Sun, X, Nahas, SA, Teraoka, S, Lai, CH, Concannon, P, et al. A. Improved diagnostic testing for ataxia-telangiectasia by immunoblotting of nuclear lysates for ATM protein expression. Mol Genet Metab. 2003;80:437–3.CrossRefGoogle ScholarPubMed
36. Orton, NC, Innes, AM, Chudley, AE, Bech-Hansen, NT. Unique disease heritage of the Dutch-German Mennonite population. Am J Med Genet. 2008;146A:1072–87.Google Scholar
37. Mitui, A, Bernatowska, E, Pietrucha, B, Piotrowska-Jastrzebska, J, Eng, L, Nahas, S, et. al. ATM gene founder haplotypes and associated mutations in Polish families with ataxia-telangiectasia. Ann Hum Genet. 2005;69:657–64.Google Scholar
38. Loeb, DM, Lederman, HM, Winkelstein, JA. Lymphoid malignancy as a presenting sign of ataxia-telangiectasia. J Pediatr Hemat Oncol. 2000;22:464–7.Google Scholar
39. Gotoff, SP, Amirmokri, E, Liebner, EJ. Ataxia telangiectasia. Neoplasia, untoward response to x-irradiation, and tuberous sclerosis. Am J Dis Child. 1967;114:617–25.CrossRefGoogle ScholarPubMed
40. Abadir, R, Hakami, N. Ataxia telangiectasia with cancer. An indication for reduced radiotherapy and chemotherapy doses. Br J Radiol. 1983;56:343–5.Google Scholar
41. Hart, RM, Kimler, BF, Evans, RG, Park, CH. Radiotherapeutic management of medulloblastoma in a pediatric patient with ataxia telangiectasia. Int J Radiat Oncol Biol Phys. 1987;13:1237–40.CrossRefGoogle Scholar
42. Pritchard, J, Sandland, MR, Breatnach, FB, Pincott, JR, Cox, R, Husband, P. The effects of radiation therapy for Hodgkin’s disease in a child with ataxia telangiectasia: a clinical, biological and pathological study. Cancer. 1982;50:877–86.Google Scholar
43. Toledano, SR, Lange, BJ. Ataxia-Telangiectasia and acute lymphoblastic leukemia. Cancer. 1980;45:1675–8.Google Scholar
44. Cunliffe, PN, Mann, JR, Cameron, AH, Roberts, KD. Radiosensitivity in ataxia-telangiectasia. Br J Radiol. 1975;48:374–6.Google Scholar
45. Morgan, JL, Holcomb, TM, Morrissey, RW. Radiation reaction in ataxia telangiectasia. Amer J Dis Child. 1968;116:557–8.Google Scholar
46. Kersey, JH, Spector, BD, Good, RA. Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry. Int J Cancer. 1973;12:333–47.CrossRefGoogle ScholarPubMed
47. Shuster, J, Hart, Z, Stimson, CW, Brough, AJ, Poulik, MD. Ataxia Telangiectasia with cerebellar tumor. Pediatr. 1966;37:776–86.Google Scholar
48. Varan, A, Büyükpamukçu, M, Ersoy, F, Sanal, Ö, Akyüz, C, Kutluk, T, et al. Malignant solid tumors associated with congenital immunodeficiency disorders. Pediatr Hematol Oncol. 2004;21:441–51.Google Scholar
49. Miyagi, K, Mukawa, J, Kinjo, N, Horikawa, K, Mekaru, S, Nakasone, S, et al. Astrocytoma linked to familial ataxia-telegiectasia. Acta Neurochir (Wien). 1995;135:87–92.CrossRefGoogle Scholar
50. Groot-Loonen, JJ, Slater, R, Taminiau, J, Voûte, PA. Three consecutive primary malignancies in one patient during childhood. Pediatr Hematol Oncol. 1988;5:287–92.Google Scholar
51. Berkel, AI, Ersoy, F. Ataxia-telangiectasia and malignancies. Turk J Pediatr. 1974;26:82–9.Google Scholar
52. Masri, AT, Bakri, FG, Al-Hadidy, AM, Musharbash, AF, Al-Hussaini, M. Ataxia-telangiectasia complicated by craniopharyngioma - a new observation. Pediatr Neurol. 2006;35:287–8.Google Scholar
53. Murphy, RC, Berdon, WE, Ruzal-Shapiro, C, Hall, EJ, Kornecki, A, Daneman, A, et al. Malignancies in pediatric patients with ataxia-telangiectasia. Pediatr Radiol. 1999;29:225–30.CrossRefGoogle ScholarPubMed
54. Liberzon, E, Avigad, S, Cohen, IJ, Yaniv, I, Michovitz, S, Zaizov, R. ATM gene mutations are not involved in medulloblastoma in children. Cancer Genet Cytogenet. 2003;146:167–9.Google Scholar
55. Hader, WJ, Drovini-Zis, K, Maguire, JA. Primitive neuroectodermal tumors in the central nervous system following cranial irradiation. Cancer. 2003;97:1072–6.CrossRefGoogle ScholarPubMed
56. Eyre, JA, Gardner-Medwin, D, Summerfield, GP. Leukoencephalopathy after prophylactic irradiation for leukemia in ataxia telangiectasia. Arch Dis Child. 1988;63:1079–93.Google Scholar
57. Lowery, MC, Sinclair-Hess, C, Carey, JC, Brothman, AR. Ataxia telangiectasia revitalized: the importance of cytogenetic analysis in the diagnosis of AT. Appl Cytogenet. 1994;20:49–51.Google Scholar
58. Kojis, TL, Gatti, RA, Sparkes, RS. The cytogenetics of ataxia-telangiectasia. Cancer Genet Cytogenet. 1992;56:143–56.Google Scholar
59. Aurias, A, Dutrillaux, B, Buriot, D, Lejeune, J. High frequencies of inversions and translocations of chromosomes 7 and 14 in ataxia telangiectasia. Mutat Res. 1980;69:369–74.Google Scholar
60. Sun, X, Becker-Catania, SG, Chun, HH, Hwang, MJ, Huo, Y, Wang, Z, et al. Early diagnosis of ataxia-telangiectasia using radiosensitivity testing. J Pediatr. 2002;140: 724–31.Google Scholar
61. Huo, YK, Wang, Z, Hong, JH, Chessa, L, McBride, WH, Perlman, SL, et al. Radiosensitivity of ataxia-telangiectasia, X-linked agamma-globulinemia, and related syndromes using a modified colony survival assay. Cancer Res. 1994;54:2544–7.Google Scholar
62. Perlman, S, Becker-Catania, S, Gatti, RA. Ataxia-Telangiectasia: diagnosis and treatment. Sem Pediatr Neurol. 2003;10:173–82.Google Scholar
63. Mitui, M, Nahas, SA, Chun, HH, Gatti, RA. Diagnosis of ataxia-telangiectasia: ATM mutation associated with cancer. In: Nakamura, RM, Grody, WW, Wu, JT, Nagle, RB, editors. Cancer diagnostics: current and future trends. Totowa, NJ: Humana Press; 2004. p. 473–87.Google Scholar
64. Nahas, SA, Butch, AW, Du, L, Gatti, RA. Rapid flow cytometry-based structural maintenance of chromosomes 1 (SMC1) phosphorylation assay for identification of ataxia-telangiectasia homozygotes and heterozygotes. Clin Chem. 2009;Jan 15. [Epub ahead of print].Google Scholar
65. Sandoval, C, Swift, M. Treatment of lymphoid malignancies in patients with ataxia-telangiectasia. Med Pediatr Oncol. 1998;31:491–7.Google Scholar